BIOCHEMICAL PROPERTIES OF ANTI-INFLAMMATORY DRUGS--III. UNCOUPLING OF OXIDATIVE PHOSPHORYLATION IN A CONNECTIVE TISSUE (CARTILAGE) AND LIVER MITOCHONDRIA BY SALICYLATE ANALOGUES: RELATIONSHIP OF STRUCTURE TO ACTIVITY.

BIOCHEMICAL PROPERTIES OF ANTI-INFLAMMATORY DRUGS--III. UNCOUPLING OF OXIDATIVE PHOSPHORYLATION IN A CONNECTIVE TISSUE (CARTILAGE) AND LIVER MITOCHONDRIA BY SALICYLATE ANALOGUES: RELATIONSHIP OF STRUCTURE TO ACTIVITY. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

BIOCHEMICAL PROPERTIES OF ANTI-INFLAMMATORY DRUGS--III. UNCOUPLING OF OXIDATIVE PHOSPHORYLATION IN A CONNECTIVE TISSUE (CARTILAGE) AND LIVER MITOCHONDRIA BY SALICYLATE ANALOGUES: RELATIONSHIP OF STRUCTURE TO ACTIVITY. Abstract Text:

M W WHITEHOUSE,

BIOCHEMICAL PROPERTIES OF ANTI-INFLAMMATORY DRUGS--III. UNCOUPLING OF OXIDATIVE PHOSPHORYLATION IN A CONNECTIVE TISSUE (CARTILAGE) AND LIVER MITOCHONDRIA BY SALICYLATE ANALOGUES: RELATIONSHIP OF STRUCTURE TO ACTIVITY. Publishing Authors By Initials

MW WHITEHOUSE,

For similar respiratory system: trachea research abstracts see: respiratory system: trachea research

PUBMED ID PMID:

MEDLINE DATE:

BIOCHEMICAL PROPERTIES OF ANTI-INFLAMMATORY DRUGS--III. UNCOUPLING OF OXIDATIVE PHOSPHORYLATION IN A CONNECTIVE TISSUE (CARTILAGE) AND LIVER MITOCHONDRIA BY SALICYLATE ANALOGUES: RELATIONSHIP OF STRUCTURE TO ACTIVITY. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Biochemical pharmacology

VOLUME: 13

Page Numbers: 319-36

Journal Abbreviation: Biochem. Pharmacol.

ISSN: 0006-2952

DAY: 24

MONTH: Mar

YEAR: 1964

BIOCHEMICAL PROPERTIES OF ANTI-INFLAMMATORY DRUGS--III. UNCOUPLING OF OXIDATIVE PHOSPHORYLATION IN A CONNECTIVE TISSUE (CARTILAGE) AND LIVER MITOCHONDRIA BY SALICYLATE ANALOGUES: RELATIONSHIP OF STRUCTURE TO ACTIVITY. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 101032

BIOCHEMICAL PROPERTIES OF ANTI-INFLAMMATORY DRUGS--III. UNCOUPLING OF OXIDATIVE PHOSPHORYLATION IN A CONNECTIVE TISSUE (CARTILAGE) AND LIVER MITOCHONDRIA BY SALICYLATE ANALOGUES: RELATIONSHIP OF STRUCTURE TO ACTIVITY. Keywords Mesh Terms:

KEYWORDS: Trachea

MESH TERMS: cytology

Chemical & Substance for Abstract: BIOCHEMICAL PROPERTIES OF ANTI-INFLAMMATORY DRUGS--III. UNCOUPLING OF OXIDATIVE PHOSPHORYLATION IN A CONNECTIVE TISSUE (CARTILAGE) AND LIVER MITOCHONDRIA BY SALICYLATE ANALOGUES: RELATIONSHIP OF STRUCTURE TO ACTIVITY. Information

Substance Name: anthranilic acid

Registry Number: 118-92-3

Grant and Affiliation Information for BIOCHEMICAL PROPERTIES OF ANTI-INFLAMMATORY DRUGS--III. UNCOUPLING OF OXIDATIVE PHOSPHORYLATION IN A CONNECTIVE TISSUE (CARTILAGE) AND LIVER MITOCHONDRIA BY SALICYLATE ANALOGUES: RELATIONSHIP OF STRUCTURE TO ACTIVITY.

AFFILIATION:

Country: ENGLAND

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Biochem Pharmacol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

BIOCHEMICAL PROPERTIES OF ANTI-INFLAMMATORY DRUGS--III UNCOUPLING OF OXIDATIVE PHOSPHORYLATION IN A CONNECTIVE TISSUE CARTILAGE AND LIVER MITOCHONDRIA BY SALICYLATE ANALOGUES: RELATIONSHIP OF STRUCTURE TO ACTIVITY Related Publications

• A study of the Elite Plus femoral component using radiostereometric analysis.
• Ano-rectal disease; incidence in 300 males of military age with particular reference to polyposis.
• Anti-inflammatory activity of emu oils in rats.
• BIOCHEMICAL PROPERTIES OF ANTI-INFLAMMATORY DRUGS--III. UNCOUPLING OF OXIDATIVE PHOSPHORYLATION IN A CONNECTIVE TISSUE (CARTILAGE) AND LIVER MITOCHONDRIA BY SALICYLATE ANALOGUES: RELATIONSHIP OF STRUCTURE TO ACTIVITY.
• BIOCHEMICAL PROPERTIES OF ANTI-INFLAMMATORY DRUGS-II. SOME EFFECTS ON SULPHATE-35S METABOLISM IN VIVO.
• BIOCHEMICAL PROPERTIES OF ANTI-INFLAMMATORY DRUGS. IV. UNCOUPLING OF OXIDATIVE PHOSPHORYLATION BY RESORCINOLS, TROPOLONES AND DIONES.
• Benign childhood epilepsy with centrotemporal spikes and the focal sharp wave trait is not linked to the fragile X region.
• Colorectal cancer. Chemotherapy.
• Emergency research and research involving subjects with cognitive impairment: ethical connections and contrasts.
• Emerging antidementia drugs: a preliminary ethical view.
• Evidence for impaired glucose tolerance in uncomplicated psoriasis. Preliminary report.
• Galileo's blunders--lessons for physician executives.
• Getting quality clinical and coded data. How UMHS's CDIP improved clinical coded data and clinical staff relationships.
• Herpesvirus saimiri ORF57: a post-transcriptional regulatory protein.
• Interesting conflicts and conflicting interests.
• Linkage analysis of idiopathic generalised epilepsy in families of probands with Juvenile Myoclonic Epilepsy and marker loci in the region of EPM 1 on chromosome 21 q: Unverricht-Lundborg disease and JME are not allelic variants.
• Microvasculature and radiation damage.
• Nutrition in the hospital patient.
• Overhead TV camera: useful addition to ultrasonic laboratory.
• Paediatric coma scales.
• Rubella before conception as a cause of foetal abnormality.
• Spontaneous sacro-iliac obliteration in patients with tuberculosis.
• Structure-action relationship among drugs acting on connective tissues (anti-rheumatic agents).
• Symptomatic venous thromboembolism after total knee replacement.
• The British National Health Service.
• The design of anti-inflammatory drugs: some considerations based on pessimism, molecular pharmacology and cellular pathology.
• Traile nmps, trailer courts, and camping sanitation.
• UNCOUPLING OF OXIDATIVE PHOSPHORYLATION BY SOME ARYLACETIC ACIDS (ANTI-INFLAMMATORY OR HYPERCHOLESTEROLEMIC DRUGS).
• Unipolar or bipolar prosthesis for displaced intracapsular hip fracture.
• Why I no longer consult for drug companies.